Position in APGE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,978,461
New position
Shares Held
22,440
first reported quarter
Ownership
0.030%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#144
of 288 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Renaissance Capital LLC holds $4,099,107 across 2 Biotechnology names. APGE ranks #1 (72.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
22,440 | $2,978,461 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
62,887 | $1,120,646 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,978,461 | 22,440 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||